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ABSTRACT
Purpose:

The purpose of this study was to examine the relationship between selfreported sedentary time (ST) and the cumulative risk of preserved ejection
fraction heart failure (HFpEF) and reduced ejection fraction heart failure
(HFrEF) using a diverse cohort of U.S. adults 45-84 years of age.

Methods:

Using data from the Multi-Ethnic Study of Atherosclerosis (MESA), we
identified 6,814 subjects (52.9% female). All were free of baseline
cardiovascular disease. Cox regression was used to calculate the hazard
ratios (HR) associated with baseline ST and risk of overall heart failure
(HF), HFpEF, and HFrEF. Weekly self-reported ST was dichotomized
based on the 75th percentile (1,890 min/wk).

Results:

During an average of 11.2 years of follow-up there were 178 first incident
HF diagnoses; 74 HFpEF, 69 HFrEF and 35 with unknown EF. Baseline
ST >1,890 min/wk was significantly associated with an increased risk of
HFpEF (HR [95% CI]; 1.87 [1.13 – 3.09], p= 0.01), but not HFrEF (HR
[95% CI]; 1.30 [0.78 – 2.15], p= 0.32). The relationship with HFpEF
remained significant in separate fully adjusted models including either
waist circumference (HR [95% CI]; 2.16 [1.23 – 3.78], p < 0.01) or body
mass index (HR [95% CI]; 2.17 [1.24 – 3.80], p < 0.01). Additionally,
every 60 minute increase in weekly ST was associated with a significant
3% increased risk of HFpEF (HR [95% CI]; 1.03 [1.01 – 1.05], p < 0.01).

Conclusions: Sedentary time > 1,890 min/wk (~ 4.5 h/d) is a significant independent
predictor of HFpEF, but not HFrEF.
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Chapter One: Introduction
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Heart failure (HF) is a chronic, progressive condition in which the myocardium is
unable to pump enough blood through circulation to meet the body's needs (1). It is
highly prevalent in older adults living in the United States (U.S.) (2, 3) and around the
world (4, 5) and is accompanied by a very poor prognosis (2, 6-9). Heart failure with
preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction
(HFrEF) are two recognized subtypes of HF with independent pathophysiological
pathways and risk factors (10, 11). Sedentary time (ST) has been shown to have a
positive relationship with overall HF incidence, independent of multiple common risk
factors, including physical activity (PA) (12).
This chapter provides an overview of relevant background information and
epidemiology pertaining to both HF and ST. A focused literature review on existing
knowledge regarding the relationship between these two topics is also included. It
concludes with the purpose and significance of this research, including the specific
questions addressed, and a description of the project. The limitations inherent to the study
design are also listed.

BACKGROUND
HEART FAILURE
According to 2017 estimates, the prevalence of HF among U.S. adults >20 years
of age is currently 6.5 million (2). By 2030, this number is projected to reach 8.5 million,
an increase of 46% from the 2012 estimates (3). Globally, based on 2014 estimates, HF
affects at least 26 million people around the world (4). At 45 years of age, the lifetime
risk of developing HF ranges from 20-45% (6). Presently, the HF prognosis is extremely
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poor; approximately 50% of people receiving a HF diagnosis will die within five years
(7, 8). In the Atherosclerosis Risk in Communities Study (13), the 30-day and 1-year case
fatality rates after hospitalization for HF were 10.4% and 22%, respectively. One in eight
deaths mentions HF on the death certificate and the number of deaths attributable to HF
has remained mostly unchanged since 1995 (9). Despite the advances in health care and
medication, the mortality and morbidity rates associated with HF remain high, while the
quality of life remains poor.
In the American Heart Association (AHA)/American College of Cardiology
guidelines (14, 15), HF is defined as a complex clinical syndrome that can result from
any structural or functional cardiac disorder that impairs the ability of the ventricle to fill
or eject blood. As such, HF has been classified according to anatomical location (leftsided or right-sided), etiology (systolic or diastolic), and contractile function (preserved
or reduced ejection fraction). However, pure right-sided heart failure is uncommon; the
most common cause of right-sided heart failure is left-sided heart failure (16-18).
Furthermore, although congestive heart failure (CHF) has historically been used
interchangeably with generalized HF, CHF is defined as a worsened state of HF in which
fluid has backed up into the lungs and peripheral tissues (1). Since not all patients have
volume overload at the time of initial or subsequent evaluation, the term heart failure is
preferred over CHF (15). Most recently, left ventricular ejection fraction, the percentage
of blood that is pumped from the left ventricle, has been used to differentiate between the
two different subtypes of left-sided HF. The demarcation points and descriptions of these
two subtypes are presented in Table 1.
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Table 1. Heart Failure Classification by Ejection Fraction
Classification

Ejection
Fraction

Description

I. Heart Failure with
Reduced Ejection
Fraction (HFrEF)

≤40%

Traditionally referred to as systolic HF. It is only
in these patients that efficacious therapies have
been demonstrated.

II. Heart Failure with
Preserved Ejection
Fraction (HFpEF)

≥50%

Traditionally referred to as diastolic HF. To date,
efficacious therapies have not been identified.

IIa. HFpEF,
borderline

41-49%

These patients fall into the borderline group. Their
characteristics, treatment patterns, and outcomes
appear similar to those of patients with HFpEF.

Note. Adapted from “ACCF/AHA guideline for the management of heart failure:
executive summary: a report of the American College of Cardiology Foundation/
American Heart Association Task Force on practice guidelines” by Yancy et al.
Circulation. 2013;128(16):1810-52.
According to Yancy et al (19), HFrEF is defined as an EF ≤ 40%, HFpEF is an EF
≥ 50%, and an EF of 41-49% is classified as borderline HFpEF. These are the cut points
that the AHA also provides (1). This differential diagnosis based on EF is crucial as
previous research has demonstrated that in addition to having different risk factors and
pathophysiology, the prognosis and response to pharmacological treatment and
rehabilitative therapy are also different among these subgroups (10, 11, 20-22). Presently,
therapeutic strategies that are successful in improving symptoms among those with
HFrEF (i.e. angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists,
beta blockers) have proven ineffective on patients with HFpEF (20-22).
Additionally, while the current prevalence of HFpEF compared to HFrEF is
similar (47% HFpEF and 53% HFrEF), the hospitalization rate for HFpEF is increasing;
the average prevalence of HFpEF hospitalizations increased from 38% to 54% in a 15year time span (22). Furthermore, racial and gender differences in the prevalence of HF
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subtypes exist, with black males having the highest proportion of hospitalized HFrEF
(70%) and white females having the highest proportion of hospitalized HFpEF (59%)
(23).
Several risk factors for overall HF have been identified. Common significant
reoccurring risk factors include coronary heart disease (CHD), hypertension (HTN),
diabetes, smoking, male gender, valvular heart disease, possessing less than a high school
education, low PA participation, and obesity (24-26). As previously mentioned, these
variables are not all significant predictors when HF is investigated independently by
HFpEF and HFrEF (10, 11, 20-22).

SEDENTARY TIME
Sedentary behavior has been defined as any waking behavior characterized by an
energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, reclining or
lying posture (27). Therefore, ST is the total amount of time spent engaging in sedentary
behaviors. This is distinctly different from physical inactivity, defined as an insufficient
amount of PA to meet present PA recommendations (28). It is possible to meet the PA
guidelines and still accumulate large amounts of ST. A 2013 systematic review (29)
reported that almost 60% of older adults report sitting for more than 4 hours per day, and
when ST was objectively measured via accelerometer, it was found that 67% of the
population are sedentary for more than 8.5 hours in their waking day. Another study by
Harvey et al. (30), found that time spent sedentary ranges from 5.3–9.4 hours per waking
day in older adults. A study utilizing a time-lapse camera and activity monitors in older
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adults found that participants appeared to frequently have vacant (non-screen) sitting time
(41% of total ST), however, screen ST was also prevalent (36% of total ST) (31).
Sedentary time has been shown to have a positive, dose-response association with
mortality from all-causes and cardiovascular disease (CVD), independent of leisure time
PA (32, 33). Additionally, a 2015 meta-analysis (34) of 47 studies also concluded that
self-reported prolonged ST was significantly associated with CVD incidence and CVD
mortality (HR, 1.14 [CI, 1.00 to 1.73] and 1.15 [CI, 1.11 to 1.20], respectively)
independent of PA. When examined as a continuous variable, each hour per day of sitting
time was associated with 2% greater risk of CVD (HR, 1.02 [CI 1.01 to 1.03] and each
MET-hour per week of PA with a 1% lower risk of CVD (HR, 0.990 [CI, 0.987 to
0.992]) (35). The AHA recently released a science advisory stating that the risk of
adverse CVD and diabetes mellitus outcomes associated with sedentary behavior must be
quantified in order for specific sedentary behavior guidelines to be established (36).

FOCUSED LITERATURE REVIEW
The evidence suggests that a significant association exists between increased PA
and decreased incidence of HF (37). A study by Pandey et al. (10) concluded that there is
a strong, dose-dependent association between PA levels, body mass index (BMI), and
risk of HF. When these investigators compared HF subtypes, higher PA levels and lower
BMI were more consistently associated with a lower risk of HFpEF compared with
HFrEF. Presently, there are a scarce number of studies that have examined the
relationship between ST and HF risk. In a study by Wijndaele et al. (12), television
viewing in hours per day was positively associated with incident HF, independent of age,
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gender, education, smoking, alcohol, hypertension, dyslipidemia, antidepressant
medication use, baseline diabetes status, family history of CVD, sleep duration and total
PA. However, there is a paucity of research regarding the relationship between ST and
the HF subtypes.

PURPOSE AND SIGNIFICANCE
In light of the poor prognosis associated with both forms of HF and the limited
treatment options currently available for HFpEF, it is vital that more research is
conducted to examine the individual risk factors associated with each class of HF to be
able to target better preventive and therapeutic strategies. Therefore, the purpose of this
study was to examine the relationship between self-reported ST and the cumulative risk
of HFpEF and HFrEF using a diverse, population-based sample of U.S. adults. The
specific research questions that were addressed include:
1. Is there an association between a higher volume of total ST and the cumulative
risk of HF, HFrEF, or HFpEF?
2. If a relationship does exist, does the relationship remain significant following
adjustment for:
a. Demographics and traditional risk factors
b. Physical activity
c. Adiposity measures (waist circumference and body mass index)
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PROJECT DESCRIPTION
This secondary analysis used data from the Multi-Ethnic Study of Atherosclerosis
(MESA) (38). The MESA consists of a population-based sample of 6,814 men and nonpregnant women aged 45-84, who were free of cardiovascular disease at baseline. The
proportional hazards regression procedure (PROC PHREG) was utilized to calculate
multivariable adjusted hazard ratios (HRs) to determine risk of HFpEF and HFrEF
according to baseline, self-reported ST. Separate regression models were constructed for
both subtypes of HF to test the relationship between several variables commonly
associated with HFpEF and HFrEF. This study was not without limitations:
1. The use of self-reported baseline ST is subject to recall and self-report bias.
Additionally, ST was not objectively measured.
2. The time to the first HF event was used to establish incident HF and EF, therefore
subsequent HF events by the same participant or changes in EF measurement over
time were not included in the analysis.
3. Baseline ST and PA were examined for all participants, changes in behavior over
the timeframe of the study were not taken into consideration for risk
determination.
4. Individuals without EF data at the time of the first HF event were not included in
the analysis.
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Heart failure (HF) refers to a complex syndrome that encompasses many cardiac
disorders that ultimately result in either one or both ventricles of the heart being unable to
fill or eject blood properly (1). Cardinal symptoms of HF include dyspnea, fatigue, and
fluid retention (2). As the heart is a very adaptive organ, the failure of the ventricles to
work efficiently is usually the product of long term compensation of the myocardium to
overcome a multitude of other potential underlying problems (i.e. hypertension (HTN),
coronary artery disease (CAD), myocardial infarction, inflammation, and ischemia).
Although HF is a chronic condition, symptoms can present acutely and progress quickly
if untreated. Right-sided HF refers to HF in which the right chambers of the heart are
affected. However, pure right-sided HF is uncommon; in fact, the most common cause of
right-sided HF is left-sided HF (3-5). Furthermore, the majority of patients with left-sided
HF have symptoms due to left ventricular (LV) myocardial dysfunction (6).
Left ventricular ejection fraction (EF) is a measurement of the amount of blood
that is ejected from the LV with each beat relative to the amount of blood present at the
end of the diastole. This diagnostic tool is used to differentiate between two types of leftsided HF: HF with reduced ejection fraction (HFrEF) and HF with preserved ejection
fraction (HFpEF). According to the American Heart Association (AHA) (2), HFrEF is
defined as an EF ≤ 40%, HFpEF is an EF ≥ 50%, and an EF of 41-49% is considered
borderline HFpEF. The pathophysiological mechanisms that lead to these two subtypes of
HF are different, multidimensional, and not fully understood at this time.
Traditionally, epidemiologic research involving HF was conducted investigating
the relationship between potential risk factors and HF as one singular outcome. As
knowledge of the different comorbidities and characteristics of patients with HFrEF and
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HFpEF unfolded, investigators began examining the potential risk predictors of HFrEF
and HFpEF independently (7). This led to the identification of differences in risk factors
for each of these HF subtypes (8-13), suggesting differing etiologies.
This chapter includes a focused history on the terminology of HFrEF and HFpEF,
an overview of the pathophysiological mechanisms related to each of these subtypes, and
a summary of the known risk factors independently associated with them. Additionally,
existing knowledge about the relationship between sedentary time (ST) and HF is
included, along with several synopses of previous research studies conducted involving
the HF subtypes. It concludes with a summary of the literature and the explanation of the
need for additional research.

TERMINOLOGY
Previously, the terms systolic and diastolic were primarily used to categorize HF,
based on the phase of the cardiac cycle in which dysfunction occurred and differences in
clinical presentation. In 2006, van Heerebeek et al. (7) investigated the distinction
between systolic heart failure (SHF) and diastolic heart failure (DHF) by comparing LV
myocardial structure and function using endomyocardial biopsy samples of patients with
known SHF and DHF. Distinct cardiomyocyte abnormalities and LV remodeling were
found to be present in each type of HF, which supported the clinical separation of HF
patients into these SHF and DHF phenotypes. Work by Katz et al. (14) illustrated that
patients with SHF had eccentric LV hypertrophy, evident by a low LV wall mass-volume
ratio, whereas patients with DHF presented with concentric LV hypertrophy or a higher
LV wall mass-volume ratio.
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The terms HFrEF and HFpEF were commonly used interchangeably with SHF
and DHF, respectively. However, because abnormalities of systolic and diastolic LV
dysfunction were found to coexist regardless of EF, SHF and DHF are no longer the
common vernacular (15-17). The terms HFrEF and HFpEF are currently recommended
by the AHA and described as being a more accurate way to categorize HF patients (2).
This is further supported by several studies that have observed differing patient
demographics, risk factors, comorbid conditions, prognosis, and therapeutic responses
based on EF (8-13, 18). The Heart Failure and Echocardiography Associations of the
European Society of Cardiology (19) also stated that structural, functional, and molecular
biological arguments support the theory that clinical HF presents and evolves not as a
single syndrome, but as two independent syndromes, one with reduced LVEF and the
other with a preserved “normal” EF.

DIAGNOSIS
The diagnosis of HF is largely clinical and based on a thorough medical history
and physical exam. The 2009 focused AHA guidelines (1) stated that three fundamental
questions must be addressed in the diagnosis of HF:
1) Is the LVEF preserved or reduced?
2) Is the structure of the LV normal or abnormal?
3) Are there other structural abnormalities such as valvular, pericardial, or right
ventricular abnormalities that could account for the clinical presentation?
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The diagnosis of HFpEF is often more complex, as it typically involves a more
thorough process of eliminating other potential cardiac disorders to ensure an accurate
diagnosis. The most recent guidelines from the AHA (20) stated that in practice, the
diagnosis of HFpEF is based on meeting the following three requirements:
1) Clinical signs or symptoms of HF
2) Evidence of preserved or normal EF
3) Evidence of abnormal LV diastolic dysfunction that can be determined by
Doppler echocardiography or cardiac catheterization

PATHOPHYSIOLOGY
As previously stated, significant evidence exists supporting the development of
HFrEF and HFpEF as two complex syndromes. They have overlapping risk factors and
possess similar clinical presentations, but consist of different pathologic myocardial
remodeling pathways that result in opposing structural and functional abnormalities.
Myocardial remodeling is used to describe a variety of changes in the biophysiology of
the cardiomyocyte, the volume and composition of cardiomyocyte and noncardiomyocyte
compartments, and the geometry and architecture of the LV chamber that occur in
response to myocardial infarction, pressure or volume overload, cardiomyopathic states,
and exposure to infectious or cardiotoxic agents (21). The complete pathological
pathways that result in HFpEF and HFrEF are not currently completely understood, but a
few well supported hypotheses have been proposed.
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HFrEF
For HFrEF, the main drivers of myocardial remodeling are a progressive loss of
cardiomyocytes resulting from cell autophagy, apoptosis, or necrosis. This cell death is
often the result of ischemia, infection, or toxicity that increases reactive oxygen species
causing oxidative stress (22). These cells are then replaced with fibrous tissue. This type
of remodeling typically results in an enlarged LV cavity that has thin, weak walls with
patchy fibrous areas and consequently reduced pumping ability. Although the size of the
cavity is enlarged and ventricular filling is not affected, the force of contraction the
myocardium is able to generate is greatly diminished. This type of cardiac hypertrophy is
typically referred to as eccentric hypertrophy.
HFpEF
In contrast, concentric hypertrophy is characteristically observed in HFpEF which
results in a thick, stiff LV wall and a reduced cavity size. While the overall EF is
preserved, a reduction in the absolute volume of blood ejected with each beat, or stroke
volume, is significantly reduced. While the theories behind the drivers of HFpEF are less
understood, the consensus appears to be that it is linked to endothelial inflammation.
Inflammation has been linked to HFpEF, but not HFrEF in several previous studies (2325). Chronic systemic inflammation affects not only the myocardium, but also other
organs such as lungs, skeletal muscles, and kidneys (26). It also affects the renal
microcirculation and the ability of the kidneys to excrete sodium, which contributes to the
progressive fluid retention observed during transition from chronic compensated to acute
decompensated HFpEF (26).
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In 2013, Paulus et al. (22) proposed a new paradigm for the development of
HFpEF which identified a systemic proinflammatory state induced by comorbidities as
the cause of myocardial structural and functional alterations. The new paradigm
presumed the following sequence of events in HFpEF: 1) a high prevalence of
comorbidities such as overweight/obesity, diabetes mellitus, chronic obstructive
pulmonary disease, and salt-sensitive hypertension induce a systemic proinflammatory
state; 2) a systemic proinflammatory state causes coronary microvascular endothelial
inflammation; 3) coronary microvascular endothelial inflammation reduces nitric oxide
bioavailability, cyclic guanosine monophosphate content, and protein kinase G (PKG)
activity in adjacent cardiomyocytes; 4) low PKG activity favors hypertrophy
development and increases resting tension because of hypophosphorylation of titin; and
5) both stiff cardiomyocytes and interstitial fibrosis contribute to high diastolic LV
stiffness and heart failure development.
SUMMARY
In summary, in HFrEF, myocardial remodeling is driven by cardiomyocyte death
due to oxidative stress originating in the cardiomyocytes as a result of ischemia,
infection, or toxicity. In HFpEF, comorbidities contribute to a systemic inflammatory
state, which induces oxidative stress in the coronary microvascular endothelium. The
location of the oxidative stress dictates the type of remodeling that occurs. In HFrEF,
eccentric hypertrophy is often observed and in HFpEF, concentric hypertrophy.
Understanding these pathways and main drivers is critical, as it allows for a better
understanding of potential preventative and therapeutic approaches. This is especially
important for HFpEF due to the lack of current successful treatment options.
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RISK FACTORS
Several prospective cohort studies have investigated the relationship between
potential risk factors and incident HFpEF and HFrEF (8-11). A summary of these studies
is presented in Table 1. Only risk factors that were significant in the fully-adjusted
models are provided. The lack of consistent findings is likely a result of the differences in
sample characteristics, definitions of HFpEF and HFrEF, and study designs.
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Table 1. Studies Reporting Significant Risk Factors for HFpEF and HFrEF
EF
Significant
Dataset
Year
Title
Authors
Definitions
HFpEF risk
Years
(n)
factors
Relation of
disease
Lee, Gona,
pathogenesis and
Vasan,
HFpEF > 45%
risk factors to
Larson,
FHS
(n=220)
HTN
2009
heart failure with
Benjamin,
1981-2004
HFrEF ≤ 45%
Female Gender
preserved or
Wang, Tu,
(n=314)
reduced ejection
Levy
fraction (8)

2013

Predictors of newonset heart failure:
differences in
preserved versus
reduced ejection
fraction (9)

Ho, Lyass,
Lee, Vasan,
Kannel,
Larson,
Levy

FHS
1981-2008

HFpEF > 45%
(n=196)
HFrEF ≤ 45%
(n=261)

Age
Diabetes
Valvular Disease
BMI
Smoking
A-Fib

Significant
HFrEF risk
factors

CHD

Age
Diabetes
Valvular Disease
Male Gender
Total Cholesterol
HR
HTN
CVD
LVH
LBBB

Incidence and
Brouwers,
epidemiology of
de Boer,
new onset heart
van der
Age
Age
failure with
Harst ,
HFpEF ≥ 50%
NT-proBNP
NT-proBNP
preserved vs.
PREVEND
Voors,
(n=125)
Female Gender
Male Gender
2013
reduced ejection
IT
Gansevoort,
HFrEF ≤ 40%
A-Fib
Smoking
fraction in a
1998-2010
Bakker,
(n=241)
UAE
Troponin T
community-based
Hillege, van
Cystatin C
Interim MI
cohort: 11-year
Veldhuisen,
follow-up of
van Gilst
PREVEND (10)
Impact of race,
BMI
HR
ethnicity, and
Silverman,
LVH
Smoking
multimodality
Patel,
Troponin T
eGFR
HFpEF ≥ 45%
biomarkers on the Blankstein,
Age
Age
MESA
(n=111)
2016
incidence of
Lima,
HTN
HTN
2000-2012
HFrEF < 45%
new-onset heart
Blumenthal,
Diabetes
Diabetes
(n=107)
failure with
Nasir,
Interim MI
Interim MI
preserved ejection
Blaha
NT-proBNP
NT-proBNP
fraction (11)
LV mass index
LV mass index
Abbreviations: HFpEF= heart failure with preserved ejection fraction; HFrEF= heart failure with reduced ejection
fraction; EF= ejection fraction; FHS= Framingham Heart Study; HTN= hypertension; CHD= coronary heart
disease; BMI= body mass index; A-Fib= atrial fibrillation; HR= heart rate; CVD= cardiovascular disease; LVH=
left ventricular hypertrophy; LBBB= left bundle branch block; NT-proBNP= N-terminal pro-brain natriuretic
peptide; UAE= urinary albumin excretion; MI= myocardial infarction; MESA= Multi-Ethnic Study of
Atherosclerosis; eGFR= estimated glomerular filtration rate; LV= left ventricle; PREVEND IT= The Prevention
of Renal and Vascular Endstage Disease Intervention Trial.

Lee et al. (8) were one of the first groups to examine antecedent clinical variables
in participants who went on to develop HFpEF (EF > 45%) and HFrEF (EF ≤ 45%).
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Using data from 314 participants in the Framingham Heart Study (FHS) who had incident
HF occurring between 1981 and 2004, they examined the age and sex adjusted odds of
risk factors associated with HFpEF versus HFrEF. The authors found that coronary heart
disease was associated with significantly reduced odds of HFpEF (Odds ratio (OR), 0.38
[CI, 0.27-0.55]). In contrast, female gender and hypertension significantly increased odds
of HFpEF (OR, 2.55 [CI 1.77-3.68]; OR, 2.13 [CI, 1.43-3.23], respectively).
In 2013, Ho et al. (9) examined the predictors of incident HFpEF and HFrEF also
using data from 6,340 participants (60 ± 12 years) who participated in the FHS between
1981 and 2008. After a mean follow-up of 7.7 years, 196 participants developed HFpEF
(EF > 45%) and 261 developed HFrEF (EF ≤ 45%). Age, diabetes, and valvular disease
were found to be significant predictors of both subtypes. Higher BMI, smoking, and atrial
fibrillation were significantly associated with HFpEF, whereas male gender, cholesterol,
heart rate, hypertension, cardiovascular disease, LV hypertrophy, and left bundle branch
block were all associated with HFrEF.
Brouwers et al. (10) investigated the prediction of new onset HFpEF compared
with HFrEF using data from 8,592 participants (28-75 years) who participated in the
Prevention of Renal and Vascular End-stage Disease (PREVEND) study. After a median
follow-up of 11.5 years, 125 participants developed HFpEF (EF ≥ 50%) and 241
developed HFrEF (EF ≤ 40%). The investigators found that age, female gender, history
of atrial fibrillation, increased urinary albumin excretion, and cystatine C were all
significantly associated with HFpEF. In contrast, male gender, smoking, increased Nterminal pro-brain-type natriuretic peptide, and increased highly sensitive troponin T
were associated with HFrEF.
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Silverman et al. (11) identified various significant risk factors for HFrEF and
HFpEF using data from 6,814 Multi-Ethnic Study of Atherosclerosis (MESA)
participants aged 45-84 years. Proportional hazard regression models were used to
identify the relationship between baseline characteristics and incident HFrEF and HFpEF.
Variables that maintained significance in multivariable adjusted analysis for HFpEF and
HFrEF are listed in adapted Table 2 and Table 3, respectively (11). Variables that did not
make a significant contribution in the multivariable analyses are not provided.

Table 2. Significant Multivariable Adjusted Risk Factors for HFpEF
Unadjusted HR
Multivariable
Variable
p-value
(95% CI)
Adjusted HR (95% CI)

p-value

Age (per SD)

2.33 (1.91–2.86)

<0.001

2.27 (1.72–3.01)

<0.001

Black Race

0.69 (0.42–1.12)

0.132

0.46(0.26–0.82)

0.009

Hypertension

3.44 (2.26–5.23)

<0.001

1.81 (1.14–2.90)

0.013

Body Mass
Index (per SD)

1.27 (1.09–1.49)

0.002

1.35 (1.08–1.68)

0.009

Diabetes

3.42 (2.29–5.11)

<0.001

2.33 (1.47–3.71)

<0.001

LVH by ECG

5.00 (2.01–12.44)

0.001

4.33 (1.70–11.04)

0.002

Interim MI

6.66 (3.91–11.34)

<0.001

4.80 (2.67–8.62)

<0.001

Abbreviations: HFpEF= heart failure with preserved ejection fraction; HR= hazard ratio; CI= confidence
interval; SD= standard deviation; LVH= left ventricular hypertrophy; ECG= electrocardiogram; MI=
myocardial infarction.

Note. Adapted from “Impact of Race, Ethnicity, and Multimodality Biomarkers on the
Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the MultiEthnic Study of Atherosclerosis)” by Silverman et al. The American Journal of
Cardiology. 2016;117(9):1474-81.
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Table 3. Significant Multivariable Adjusted Risk Factors for HFrEF
Unadjusted HR
Multivariable Adjusted
Variable
p-value
p-value
(95% CI)
HR (95% CI)
Age (per SD)

1.72 (1.44–2.07)

<0.001

1.30 (1.00–1.70)

0.048

Female

0.34 (0.23–0.53)

<0.001

0.34 (0.21–0.56)

<0.001

Chinese

0.08 (0.01–0.58)

0.013

0.14 (0.02–1.00)

0.05

Heart Rate
(per SD)

1.26 (1.04–1.53)

0.019

1.25 (1.03–1.51)

0.022

Hypertension

3.26 (2.14–4.97)

<0.001

2.04 (1.23–3.36)

0.003

Current
Smoking

1.68 (1.04–2.70)

0.034

2.00 (1.19–3.36)

0.009

Diabetes

2.87 (1.88–4.38)

<0.001

1.84 (1.13–3.00)

0.014

eGFR (per
SD)

1.60 (1.29–1.99)

<0.001

1.29 (1.04–1.59)

0.019

Interim MI

4.81 (2.65–8.71)

<0.001

2.56 (1.32–4.97)

0.005

5.11 (3.27–7.98)

<0.001

5.00 (2.70–9.25)

<0.001

1.88 (1.59–2.22)

<0.001

1.94 (1.68–2.25)

<0.001

NT-proBNP
> 75th
percentile
LV mass
index (per SD)

Abbreviations: HFrEF= heart failure with reduced ejection fraction; HR= hazard ratio; LV= left
ventricular; NT-proBNP= N-terminal pro-brain natriuretic peptide; MI= myocardial infarction; eGFR=
estimated glomerular filtration rate; LV= left ventricular; SD= standard deviation.

Note. Adapted from “Impact of Race, Ethnicity, and Multimodality Biomarkers on the
Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the MultiEthnic Study of Atherosclerosis)” by Silverman et al. The American Journal of
Cardiology. 2016;117(9):1474-81.
HF and SEDENTARY TIME
Sedentary behavior has been defined as any waking behavior characterized by an
energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, reclining or
lying posture (27). Therefore, sedentary time (ST) is the total amount of time spent
engaging in sedentary behaviors. This is distinctly different from physical inactivity,
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defined as an insufficient amount of PA to meet present PA recommendations (28). It is
possible to meet the PA guidelines and still accumulate large amounts of ST. Sedentary
time has been shown to have a positive, dose-response association with mortality from
all-causes and cardiovascular disease (CVD), independent of leisure time PA (29, 30).
Additionally, a 2015 meta-analysis (31) of 47 studies also concluded that self-reported
prolonged ST was significantly associated with CVD incidence and CVD mortality (HR,
[95% CI]; 1.14 [ 1.00 - 1.73] and 1.15 [ 1.11 - 1.20], respectively) independent of PA.
When examined as a continuous variable, each hour per day of sitting time was
associated with 2% greater risk of CVD (HR [95% CI]; 1.02 [1.01 - 1.03] and each METhour per week of PA with a 1% lower risk of CVD (HR, [95% CI]; 0.99 [0.99 - 0.99])
(32).
Presently, there are a scarce number of studies that have examined the
relationship between ST and HF risk. Young et al (33) examined the relationship between
sedentary time and incident HF in 82,694 men 45 years of age and older from the
California Men’s Health Study. After 10 years of follow-up, 3,473 men developed HF.
Controlling for sociodemographics, hypertension, diabetes, hyperlipidemia, body mass
index, smoking, diet, and PA, those in the medium ST category (HR [95% CI]; 1.13
[1.04-1.24]) and the highest ST category (HR [95% CI]; 1.34 [1.21 – 1.48]) had
significantly increased risk of HF compared to those in the lowest ST category.
Additionally, in a study by Wijndaele et al. (34), the investigators examined the
association between television viewing time and incident HF in 12,608 men and women
from the EPIC Norfolk Study. They found that television viewing (hours/day) was
significantly associated with incident HF, independent of age and gender (HR [95%CI];

28

1.15 [1.05–1.25]), education, smoking, alcohol, hypertension, dyslipidaemia,
antidepressant medication, baseline diabetes status, family history of CVD, sleep duration
(HR [95%CI]; 1.11 [1.01–1.21]), and total PA (HR [95%CI]; 1.10 [1.01–1.20]).
However, there is a paucity of research regarding the relationship between ST and the HF
subtypes.

RELEVANT HFpEF/HFrEF RESEARCH
Higher levels of physical activity (PA), high cardiorespiratory fitness, lack of
obesity and low ST have all been shown to be associated with reductions in overall HF
risk (27, 35-44). The relationship between these variables and the risk of HFpEF and
HFrEF subtypes is less explored. This section highlights several studies that have
investigated some of these relationships.
HFpEF/HFrEF AND PHYSICAL ACTIVITY
Kraigher-Krainer et al. (45) evaluated an average of 10 years of follow-up data
from 1,142 participants of the FHS. Participants answered questions about their PA
participation via a questionnaire administered at baseline. Tertiles of PA were created
based on total self-reported PA. Over the course of the study, 108 participants developed
HFpEF and 106 HFrEF. In age- and sex-adjusted models, the middle and highest PA
tertiles were associated with a significant 15-40% lower risk of HFrEF, and 41-66%
lower risk of HFpEF, with a graded response across tertiles. In multivariable models, the
association of higher PA with lower risk of HFPEF retained significance, whereas the
significant association with HFREF was lost.
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Pandey et al. (12) investigated the relationship between leisure time physical
activity (LTPA) and risk of HFpEF and HFrEF using pooled data from three large,
prospective, cohort studies; the Women’s Health Initiative, the MESA, and the
Cardiovascular Health Study. The total sample included 51,451 participants free of
baseline HF. Participants were stratified into four different LTPA categories: 1) No
LTPA; 2) 1 to <500 MET-min/week; 3) 500 to 1,000 MET-min/week; 4) >1,000 METmin/week. After 645,515 person-years of follow-up, 3,180 HF events were observed,
1,252 HFpEF (≥ 45% EF) and 914 HFrEF (< 45% EF). Separate multivariable adjusted
Cox proportional hazards models were created to determine the risk of HFpEF and
HFrEF according to baseline LTPA and BMI category. Adjusted models revealed no
significant associations between LTPA and HFrEF at any level. In contrast, HFpEF was
found to have a significant dose-dependent association with LTPA levels (p for trend
< 0.01).
HFpEF/HFrEF AND OBESITY
Ho et al. (9) and Silverman et al. (11) both observed a significant relationship
between BMI and HFpEF, but not HFrEF. The study by Pandey et al. (12) investigated
the relationship between BMI and risk of overall HF and its subtypes in detail.
Participants were placed into five separate categories based on baseline BMI: 1)
underweight; 2) normal weight (referent group); 3) overweight; 4) obese class I; and 5)
obese class II-III. The investigators found that participants with a higher BMI (when
compared to desirable BMI) had a positive, graded increase in risk of HFpEF, such that
compared to normal weight participants, overweight, obese class I, and obese class II-III
participants had 38%, 56%, and 172% higher risk of HFpEF, respectively. A significant
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increase in risk for HFrEF was not observed in overweight, or obese class I individuals,
only in obese class II-III. In linear contrast analysis, a significant dose-response
association was found between BMI and HFpEF (p < 0.01), but not HFrEF.

SUMMARY
In summary, HFpEF and HFrEF are two subtypes of left-sided HF that have
independent risk profiles and causal pathways. These causal pathways are typically
driven by either several potential comorbidities that cause systemic inflammation, cardiac
insult and cell death, or a combination of both. Depending on the original cause(s),
differing patterns of cardiac remodeling occur, resulting in different structural and
functional abnormalities. In the case of HFpEF, there are currently no effective
therapeutic or pharmaceutical interventions available, therefore it is crucial to focus on
identifying risk factors and prevention strategies. Additionally, HFpEF is more
commonly associated with metabolic comorbidities, low levels of PA, and increased
obesity than HFrEF. All of these are modifiable lifestyle risk factors that could be
potential targets of prevention. As ST is also a modifiable lifestyle risk factor that has
been shown to be associated with increased risk of HF, independent of PA, the
examination of ST and the risk of HF subtypes is both warranted and necessary.
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Chapter Three: Methodology
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The purpose of this study was to examine the associations between sedentary time
(ST) and the risk of overall heart failure (HF), heart failure with preserved ejection
fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). If a
relationship between any of these variables was observed, the secondary aim was to see if
the relationship was maintained after controlling for:
1) Demographics and traditional risk factors
2) Physical activity (PA)
3) Adiposity measures (waist circumference [WC] and body mass index [BMI])
This section provides the details of the methodology that was used to address these
research questions.

DATA COLLECTION
This study utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA), an
ongoing population-based study sponsored by the National Heart Lung and Blood
Institute of the National Institutes of Health. Details on this study have been published
elsewhere (1). The sample (n= 6,814) consisted of men and women (45-84 years of age)
who were free of baseline cardiovascular disease (CVD) upon enrollment. Participants
were recruited from six different field centers at Universities across the United States:
1)

University of California, Los Angeles, CA

2)

University of Minnesota, St. Paul, MN

3)

Northwestern University, Chicago, IL

4)

Wake Forest University, Winston-Salem, NC

5)

John Hopkins University, Baltimore, MD
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6)

Columbia University, New York, NY

MESA's exclusion criteria were:
1)

Age younger than 45 or older than 84 years

2)

Physician-diagnosed heart attack

3)

Physician-diagnosed angina or taking nitroglycerin

4)

Physician-diagnosed stroke or transient ischemic attack

5)

Physician-diagnosed heart failure

6)

Current atrial fibrillation

7)

Having undergone procedures related to cardiovascular disease (CABG,
angioplasty, valve replacement, pacemaker or defibrillator implantation,
any surgery on the heart or arteries)

8)

Active treatment for cancer

9)

Pregnancy

10)

Any serious medical condition which would prevent long-term
participation

11)

Weight >300 pounds

12)

Cognitive inability as judged by the interviewer

13)

Living in a nursing home or on the waiting list for a nursing home

14)

Plans to leave the community within five years

15)

Language barrier (speaks other than English, Spanish, Cantonese or
Mandarin)

16)

Chest CT scan in the past year
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The MESA utilized both physical exams and questionnaires to examine the
characteristics of subclinical CVD and the risk factors that predict progression to
clinically overt CVD. The first exam took place from July 2000-July 2002, and a total of
four additional follow-up exams were completed by 2012. Participants are continuously
contacted every 9-12 months to assess clinical morbidity and mortality data.
The present study was reviewed and approved by the Institutional Review Board of the
University of North Florida (Appendix A). Data from the MESA was requested and
obtained from the National Institutes of Health/ National Heart, Lung, and Blood
Institute: Biologic Specimen and Data Repository Information Coordinating Center (2).
A copy of the signed research materials data agreement (RMDA) is provided in
Appendix B.

PRIMARY DEPENDENT VARIABLE
The primary outcome was time to congestive heart failure (TTCHF), classified as
either definite or probable. Congestive heart failure (CHF) was an adjudicated event in
MESA, determined by a panel of physicians following review of medical records.
Probable CHF was defined as: CHF diagnosed by physician and patient receiving
medical treatment for CHF. Definite CHF determination required evidence of pulmonary
edema/congestion, dilated ventricle, poor left ventricular function, or evidence of left
ventricular diastolic dysfunction. Those with an ejection fraction (EF) ≤ 40% at time of
diagnosis were classified as HFrEF and those with an EF > 40% were classified as
HFpEF.
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PRIMARY INDEPENDENT VARIABLE
Self-reported baseline ST based on the typical week physical activity survey (TWPAS)
completed by all MESA participants was the primary independent variable in this study.
The following questions from the TWPAS were used to estimate total weekly ST:
1.

“In a typical week in the past month, did you sit or recline and watch TV?”

2.

“In a typical week in the past month, did you read, knit, sew, visit, do nothing,

non-work recreational computer?”
Responses included yes or no, days per week (1-7days), hours per day (1-5 or 5+ hours),
and minutes per day (5, 15, 30, or 45 minutes). Total hours per day (converted to
minutes) and minutes per day were summed and multiplied by days per week to
accumulate estimated minutes per week of ST.

[(HR/DAY * 60 MN/HR) + MIN/DAY] * DAYS/WK = MIN/WK TOTAL ST

This variable was then used to create two separate variables used in further
analysis: SEDDICHOT, a variable dichotomized around the 75th percentile (≤ or > 1,890
min/wk) and SEDHOURS, a variable that represented every 1 hour interval of weekly
ST.

OTHER INDEPENDENT VARIABLES
The potential confounding variables that were controlled for in this study included the
following:
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AGE
Age was self-reported on the personal history form at exam one. This was
included in the analysis as a continuous controlling variable.
SEX
Sex was self-reported on the personal history form at exam one as either male or
female.
RACE
Race was self-reported on the personal history form at exam one as either
Caucasian, Chinese, African American, or Hispanic.
SMOKING
Smoking status was self-reported on the personal history form at exam one. The
question stated, “Have you smoked cigarettes in the past 30 days?’ Responses included
yes or no.
HYPERTENSION
Self-reported based on the medical history form given at exam one. The question
stated, “Has a doctor ever told you that you had high blood pressure or hypertension?”
Responses included yes, no, or I don’t know. The response ‘I don’t know’ was recoded as
a missing variable.
DIABETES
Self-reported based on the medical history form given at exam one. The question
stated, “Has a doctor ever told you that you had Diabetes (sugar in blood)?” Responses
included yes, no, or I don’t know. The response ‘I don’t know’ was recoded as a missing
variable.
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METABOLIC SYNDROME
Metabolic Syndrome was a calculated variable in MESA based on participants’
measured waist circumference, triglycerides, high density lipoprotein cholesterol, blood
pressure, and fasting blood glucose. The MESA utilized the National Cholesterol
Education Program Guidelines (4) to define metabolic syndrome.

PHYSICAL ACTIVITY
An intentional physical activity variable was created in MESA that combined
responses on the TWAPAS about time spent participating in the following activities
(Questions 9-15):
1)

Walking for exercise, pleasure, social reasons, walking during work breaks, and
walking the dog is classified as intentional walking.

2)

Dancing in church, ceremonies, or for pleasure.

3)

Team sports such as softball, volleyball, basketball, or soccer.

4)

Dual sports such as tennis, racketball, and paddleball.

5)

Individual activities such as golf, bowling, yoga, or t’ai chi.

6)

Moderate effort conditioning activities such as low impact aerobics, recreational
(slow) bicycling, rowing on a rowing machine or in a lake, swimming in a pool or
lake, or using weight lifting or conditioning machines at a health club.

7)

Heavy effort conditioning activities such as high impact aerobics (e.g., Tai-bo,
kick boxing, judo, karate), competitive or maximum effort running, bicycling,
swimming, and work on health club machines.
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BODY MASS INDEX
Body mass index was calculated as body weight in kilograms (kg) divided by
height in meters squared (m2) using measurements obtained at exam one.
WAIST CIRCUMFERENCE
Waist circumference was measured at exam one in centimeters (cm).

STATISTICAL ANALYSIS
Data was managed utilizing SAS 9.4 (3) where complex variable recodes, coding
verification, and statistical analyses were performed. The means and frequency
procedures (PROC MEANS and PROC FREQ) were used to construct a descriptive
characteristics table for continuous and categorical variables, respectively. The univariate
procedure (PROC UNIVARIATE) was used to determine the 75th percentile of selfreported ST.
Separate proportional hazards regression procedures (PROC PHREG) were
utilized to calculate multivariable adjusted hazard ratios (HRs) to determine risk of
overall HF, HFpEF and HFrEF according to baseline ST. Incident HF without data on
ejection fraction were excluded from the HF subtype analysis. Five separate models were
constructed for each of the outcome variables. Model one was unadjusted. Model two
controlled for age, sex, race, smoking, hypertension, diabetes, and metabolic syndrome.
Model three controlled for all variables in model two plus P A. Finally, two separate
adiposity models were created due to the high collinearity of BMI and WC. Model four
controlled for all variables in model three plus BMI. Model five controlled for all
variables in model three plus WC.
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ABSTRACT
Purpose:

The purpose of this study was to examine the relationship between selfreported sedentary time (ST) and the cumulative risk of preserved ejection
fraction heart failure (HFpEF) and reduced ejection fraction heart failure
(HFrEF) using a diverse cohort of U.S. adults 45-84 years of age.

Methods:

Using data from the Multi-Ethnic Study of Atherosclerosis (MESA), we
identified 6,814 subjects (52.9% female). All were free of baseline
cardiovascular disease. Cox regression was used to calculate the hazard
ratios (HR) associated with baseline ST and risk of overall HF, HFpEF,
and HFrEF. Weekly self-reported ST was dichotomized based on the 75th
percentile (1,890 min/wk).

Results:

During ~11.2 years of follow-up there were 178 first incident HF
diagnoses; 74 HFpEF, 69 HFrEF and 35 with unknown EF. Baseline ST
>1,890 min/wk was significantly associated with an increased risk of
HFpEF (HR [95% CI]; 1.87 [1.13 – 3.09], p= 0.01), but not HFrEF (HR
[95% CI]; 1.30 [0.78 – 2.15], p= 0.32). The relationship with HFpEF
remained significant in separate fully adjusted models including either
waist circumference (HR [95% CI]; 2.16 [1.23 – 3.78], p < 0.01) or body
mass index (HR [95% CI]; 2.17 [1.24 – 3.80], p < 0.01). Additionally,
every 60 minute increase in weekly ST was associated with a significant
3% increased risk of HFpEF (HR [95% CI]; 1.03 [1.01 – 1.05], p < 0.01).

Conclusions: Sedentary time >1,890 min/wk (~4.5 h/d) is an independent predictor of
HFpEF, but not HFrEF.
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INTRODUCTION
According to 2017 estimates (1), the prevalence of heart failure (HF) among U.S.
adults is currently 6.5 million. By 2030, this number is projected to reach 8.5 million, an
increase of 46% from 2012 estimates (2). At 45 years of age, the lifetime risk of
developing HF ranges from 20 - 45% (3). Presently, the prognosis after being diagnosed
with HF is extremely unpromising; approximately 50% of people diagnosed will die
within five years (4, 5, 6). In general, HF is a complex clinical syndrome that can result
from any cardiac disorder that impairs the ability of the ventricle to function properly (7).
The majority of HF cases affect the left ventricle of the heart, and as left-sided HF is the
most common cause of right-sided HF, this is the focus of most HF research. Two
subtypes of left-sided HF are currently recognized: heart failure with reduced ejection
fraction (HFrEF) and preserved ejection fraction (HFpEF) (7, 8).
According to Yancy et al. (8), HFrEF is defined as an EF ≤ 40%, HFpEF is an EF
≥ 50%, and an EF of 41 - 49% is considered borderline HFpEF. This differential
diagnosis based on EF is crucial as previous research has demonstrated that the risk
factors, pathophysiology, prognosis and response to pharmaceutical and rehabilitative
therapy are different among these subtypes (9-14). In HFrEF, myocardial remodeling is
driven by cardiomyocyte death due to oxidative stress originating in the cardiomyocytes
as a result of ischemia, infection, or toxicity, whereas in HFpEF, comorbidities contribute
to a systemic inflammatory state, which induces oxidative stress in the coronary
microvascular endothelium (14). Presently, therapeutic strategies that are successful in
improving symptoms among those with HFrEF have proven ineffective on patients with
HFpEF (9, 10). Therefore, identifying modifiable risk factors, such as sedentary time
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(ST), which may play a role in the development of the different subtypes of HF are
critical for developing effective prevention strategies.
Sedentary behavior has been defined as any waking behavior characterized by an
energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, reclining or
lying posture (15). Therefore, ST is the total amount of time spent engaging in sedentary
behaviors. This is distinctly different from physical inactivity, defined as an insufficient
amount of physical activity (PA) to meet present PA recommendations (16). A recent
meta-analysis of 47 studies concluded that self-reported prolonged ST was significantly
associated with CVD incidence and CVD mortality (HR [95%CI]; 1.14 [1.00-1.73 and
1.15 [1.11-1.20], respectively) independent of PA (17). Young et al (18) found a
significant association between increased ST and HF risk. Additionally, a study by
Wijndaele at al (19) observed that television viewing time, a form of ST, was positively
associated with incident HF, independent of PA. However, little is known about the
relationship between ST and the risk of the different subtypes of HF.
The purpose of this study was to examine the relationship between self-reported
ST and the cumulative risk of HFpEF and HFrEF using a diverse, population-based
sample of U.S. adults. Based on the inflammatory driven pathophysiology and common
cardiometabolic risk factors associated with HFpEF, along with previous research
demonstrating a stronger relationship with lower PA and higher BMI and HFpEF (12),
we hypothesized that a higher volume of sedentary time would be associated with
increased risk of HFpEF, but not HFrEF.
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METHODS
This study analyzed data from the MESA (20), a continuous survey sponsored by
the National Heart Lung and Blood Institute of the National Institutes of Health. The
MESA is a diverse, population based sample that examines the characteristics of
subclinical cardiovascular disease and the risk factors that predict progression to
clinically overt cardiovascular disease or progression of the subclinical disease. Details
on this study have been published elsewhere (20). In brief, the sample (n= 6,814)
consisted of men and women (45-84 years of age) who were free of baseline
cardiovascular disease (CVD) upon enrollment. The MESA utilized both physical exams
and questionnaires. The first exam took place from July 2000-July 2002, and a total of
four additional follow-up exams were completed by 2012. Participants are continuously
contacted every 9-12 months to assess clinical morbidity and mortality data. Data from
the MESA was requested and obtained from the National Institutes of Health/ National
Heart, Lung, and Blood Institute: Biologic Specimen and Data Repository Information
Coordinating Center (21). The use of MESA data was approved by the Institutional
Review Board of the University of North Florida.
Dependent Variable: Heart failure, classified as either definite or probable, was an
adjudicated event in MESA determined by a panel of physicians following review of
patient medical records. Probable HF was defined as: HF diagnosed by physician and
patient receiving medical treatment for HF. Definite HF determination required
additional evidence of pulmonary edema or congestion, dilated ventricle, poor left
ventricular function, or left ventricular diastolic dysfunction. In the present study, those
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with an EF ≤ 40% at time of diagnosis were classified as HFrEF, and those with a
borderline EF (41 - 49%) or an EF ≥ 50% were classified HFpEF.
Independent Variable: Self-reported, baseline ST based on the typical week
physical activity survey (TWPAS) completed by all MESA participants. The following
questions from the survey were used to estimate total weekly sedentary minutes: “In a
typical week in the past month, did you sit or recline and watch TV?” and “In a typical
week in the past month, did you read, knit, sew, visit, do nothing, non-work recreational
computer?” Responses included yes or no, days per week (1 - 7), hours per day (1 - 5 or 5
+), and minutes per day (5, 15, 30, or 45). Total hours per day (converted to minutes) and
minutes per day were summed and multiplied by days per week to accumulate an
estimated minutes per week of ST. Total weekly ST was then used to create two ST
variables, one dichotomized at the 75th percentile (≤ or > 1,890 min/wk) and one that
represented every 60 minute interval of ST.
Other independent measures: Age, sex, race, and smoking status were selfreported at baseline on the personal history form. Hypertension and diabetes were also
self-reported at baseline on the medical history form. Metabolic Syndrome was a
calculated variable in MESA based on participants’ measured waist circumference,
triglycerides, high density lipoprotein cholesterol, blood pressure, and fasting blood
glucose. The MESA utilized the National Cholesterol Education Program Guidelines (21)
to define metabolic syndrome. The intentional exercise measure using several questions
from the TWPAS including walking, sport/dance, and conditioning, reported in METminutes per day, was used to determine risk independent of PA. Body mass index (BMI)
was calculated as body weight in kilograms (kg) divided by height in meters squared (m2)
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using measurements obtained at exam one. Waist circumference (WC) was also measured
at exam one in centimeters (cm).
Statistical Analysis: Data was managed utilizing SAS 9.4 (22) where complex
variable recodes, coding verification, and statistical analyses were performed. The means
and frequency procedures (PROC MEANS and PROC FREQ) were used to construct a
descriptive characteristics table for continuous and categorical variables, respectively.
The univariate procedure (PROC UNIVARIATE) was used to determine the 75th
percentile of self-reported ST. Separate proportional hazards regression procedures
(PROC PHREG) were utilized to calculate multivariable adjusted hazard ratios (HRs) to
determine risk of overall HF, HFpEF and HFrEF according to baseline ST. Incident HF
without data on ejection fraction were excluded from the HF subtype analysis.
Five separate models were constructed for each of the outcome variables. Model
one was unadjusted. Model two controlled for age, sex, race, smoking, hypertension,
diabetes, and metabolic syndrome. Model three controlled for all variables in model two
plus PA. Finally, two separate adiposity models were created due to the high collinearity
of BMI and WC. Model four controlled for all variables in model three, plus BMI. Model
five controlled for all variables in model three, plus WC.

RESULTS
Among the 178 subjects that developed HF, 143 subjects had a known EF at the
time of HF diagnosis. Of those, 74 were categorized HFpEF and 69 HFrEF. Table 1
contains the baseline characteristics, including demographics, race, clinical
characteristics, and ST according to HFpEF, HFrEF, overall HF and no HF. The
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multivariable adjusted HRs derived from the proportional hazards regression procedure
for overall HF, HFpEF, and HFrEF are presented in Table 2. While baseline ST > 1,890
min/wk was borderline significant, with a 38% increased risk of overall HF in the
unadjusted model (HR [95%CI]; 1.38 [1.00-1.89], p= 0.05), this relationship was
attenuated with further adjustments for demographics, common risk factors, PA, and
adiposity measures, and did not remain significant. Baseline ST was not significantly
associated with risk of HFrEF in any model.
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Table 1. Baseline Characteristics
HFrEF
(n = 69)

HFpEF
(n = 74)

Overall HF
(n = 178)

No HF
(n = 6,636)

68 (± 9.0)

69 (± 8.6)

69 (± 8.7)

62 (± 10.2)

49 (71.0%)

38 (51.4%)

106 (59.6%)

3,107 (46.8%)

White

28 (40.6%)

32 (43.2%)

69 (38.8%)

2,553 (38.5%)

African American

28 (40.6%)

18 (24.3%)

61 (34.3%)

1,831 (27.6%)

Hispanic

13 (18.8%)

15 (20.3%)

38 (21.4%)

1,458 (22.0%)

Chinese

0 (0.0%)

9 (12.2%)

10 (5.6%)

794 (12.0%)

Heart Rate (bpm)

64 (± 11.5)

64 (± 9.8)

65 (± 11.1)

63 (± 9.6)

BMI (kg/m2)

29.2 (± 5.1)

30.3 (± 6.0)

30.2 (± 6.2)

28.3 (± 5.4)

WC (cm)

104.1 (± 18)

105.6 (± 15.1)

105.7 (± 17.3)

98.0 (± 14.3)

Hypertension

51 (73.9%)

58 (78.4%)

135 (75.8%)

2,923 (44.1%)

Metabolic Syndrome

33 (47.8%)

44 (59.5%)

96 (53.9%)

2,353 (35.6%)

Diabetes

19 (27.9%)

25 (33.8%)

56 (31.6%)

717 (10.8%)

Current Smoking

15 (21.7%)

8 (10.8%)

28 (15.7%)

860 (13.0%)

1,687.3

1,595.3

1,648.0

1,427.4

≤ 1,890 min/week

45 (66.2%)

50 (67.6%)

119 (67.2%)

5,001 (75.6%)

> 1,890 min/week

23 (33.8%)

24 (32.4%)

58 (32.8%)

1,617 (24.4%)

Total n = 6,814
Demographics
Age (years)
Male
Race/Ethnicity

Clinical Characteristics

Sedentary Time
Average (min/week)

Values are expressed in mean (SD) for continuous variables and n (%) for categorical variables.
Abbreviations: HF = heart failure; HFpEF = heart failure with preserved ejection fraction; HFrEF
= heart failure with reduced ejection fraction; BMI = body mass index (kg/m2); WC = waist
circumference (cm).
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Table 2. Hazard Ratios Associated with Sedentary Time (ST) >1,890 min/wk and Risk of Incident
Heart Failure
Overall HF
HFpEF
HFrEF
HR [95% CI]

P-value

HR [95% CI]

P-value

HR [95% CI]

P-value

Model 1

1.38 [1.00-1.89]

0.05

1.87 [1.13-3.09]

0.01

1.30 [0.78-2.15]

0.32

Model 2

1.25 [0.89-1.74]

0.20

1.90 [1.09-3.30]

0.02

1.15 [0.66-2.00]

0.62

Model 3

1.25 [0.90-1.75]

0.19

1.92 [1.10-3.36]

0.02

1.15 [0.66-2.00]

0.63

Model 4

1.25 [0.89-1.75]

0.20

2.16 [1.23-3.78]

< 0.01

1.20 [0.64-2.23]

0.57

Model 5

1.23 [0.88-1.72]

0.24

2.17 [1.24-3.80]

< 0.01

1.18 [0.65-2.15]

0.58

0.28
1.03 [1.01-1.05]
< 0.01
1.01 [0.99-1.02]
0.57
Per 60 min ST 1.01 [1.00-1.02]
Model 1: unadjusted
Model 2: adjusted for age, sex, race, smoking, hypertension, diabetes, and metabolic syndrome
Model 3: model 2 additionally adjusted for physical activity (METS)
Model 4: model 3 additionally adjusted for waist circumference (cm)
Model 5: model 3 additionally adjusted for body mass index (kg/m2)
Per 60 min ST: adjusted for all variables in model 4
Abbreviations: min/wk= minutes per week; HFpEF= heart failure with preserved ejection fraction;
HFrEF= heart failure with reduced ejection fraction; HR= hazard ratio; CI= confidence interval.

In the unadjusted model, baseline ST > 1,890 min/wk was significantly associated
with an 87% increased risk of HFpEF (HR [95% CI]; 1.87 [1.13-3.09]) when compared
to those with ST ≤ 1,890 min/wk. The relationship remained significant following
adjustment for age, sex, race, smoking, hypertension, diabetes, and metabolic syndrome
(HR [95% CI]; 1.90 [1.09-3.30]). The addition of PA (HR [95% CI]; 1.92 [1.10-3.36]),
and adiposity measures WC (HR [95% CI]; 2.16 [1.23-3.78]) and BMI (HR [95% CI];
2.17 [1.24-3.80]) did not attenuate significance. Similarly, when ST was evaluated for
every 60 minute increase, a significant relationship was only observed with HFpEF.
Every 1 hour increase in weekly ST was associated with a 3% increased risk of HFpEF
(HR [95% CI]; 1.03 [1.01-1.05]), independent of all variables in model 4. A 1%
increased risk was observed for overall HF that was borderline significant (p= 0.06) in
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the crude model, however significance was lost following further adjustment. No such
relationship was observed with HFrEF.

DISCUSSION
In the current study, a statistically significant relationship between a higher
volume of ST and risk of HFpEF was observed. Additionally, this relationship remained
significant when demographics, several traditional risk factors, intentional exercise, and
adiposity measures were added to the model. Furthermore, for every hour of increased
weekly ST, a significant 3% increased risk of HFpEF was observed. Borderline
significance in the crude model was observed for overall HF, however this was attenuated
following further adjustment. No association between ST and risk of HFrEF was detected
in any of the models.
Several studies have found an association between higher volumes of ST and
increased risk of overall HF (18, 19), however the relationship between ST and the HF
subtypes was previously unexplored. Recently, a study by Pandey et al (12) demonstrated
an inverse, dose-response relationship between leisure-time PA and risk of overall HF
and HFpEF, but not HFrEF. The authors suggested that this association is likely due to
the different potential mechanisms in which PA lowers cardiovascular risk and the
difference in the pathophysiology of HFpEF and HFrEF. As lower amounts of ST,
independent of PA, are also associated with lower cardiovascular risk (17), this rationale
could also potentially explain the relationship between HFpEF and ST.
This study adds to the literature by characterizing, for the first time, the positive
relationship between ST and risk of HFpEF, independent of intentional exercise and
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adiposity. This study suggests that spending > 4.5 h/d sedentary, regardless of intentional
exercise or adiposity, significantly increases risk of HFpEF. Reducing ST, along with
increasing PA, should be emphasized to prevent the development of HFpEF and should
be a therapeutic target to potentially prevent the pathological progression of HFpEF.
Future studies should investigate ST objectively, and seek to establish a target goal for
ST recommendations for this population.
This study was not without limitations. The use of self-reported baseline ST is subject
to recall and self-report bias. Additionally, ST was not objectively measured. The time to
the first HF event was used to establish incident HF and EF, therefore subsequent HF
events by the same participant or changes in EF measurement over time were not
included in the analysis. Baseline ST and PA were examined for all participants, changes
in behavior over the timeframe of the study were not taken into consideration for risk
determination. Individuals without EF data at the time of the first HF event were not
included in the analysis.
In conclusion, ST is positively associated with the cumulative risk of HFpEF.
This relationship is independent of demographics, traditional risk factors, intentional
exercise, and adiposity measures. This identifies a potential area of intervention for
preventing HFpEF and adds to the evidence of HFpEF and HFrEF having separate causal
pathways and risk factors.
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